While interest in shared decision-making has increased rapidly in recent years, there remains a lot to be done to align palliative and end-of-life care with patients' values across different healthcare systems. The concept of shared decision-making is most commonly defined as the process of integrating both the best available evidence and patients' values and preferences in the decision-making process. 1 While there is consensus that palliative and endof-life care decisions are preference sensitive and therefore an appropriate context for the involvement of patients and family caregivers in decision-making, it is not the most studied area of application. There are dozens of decision aids about cancer screening (e.g. see the Ottawa Decision Aide Inventory), but relatively few focus on end-of-life care issues. The imperative to discuss patient preferences as a way to reduce overly aggressive end-oflife care is nonetheless widely recognized. The authors of a national study of end-of-life care patterns in the United States concluded that there was an increase in the use of intensive care and in transitions during the last 3 days of life between 2000 and 2009, despite the development of hospice and palliative care services. 2 The combined pressures of population aging and the continued large amount of resource utilization toward the end of life make the respect of patient preferences an enduring topic of interest in health policy and practice research across the world. In this context, five areas of research appear particularly salient at the intersection of shared decision-making and palliative care research, and deserve to be studied further, namely, the need to observe decision-making interactions directly, to capture patient perceptions of decision-making processes, to target non-cancer palliative care populations, to explore health systems factors that encourage valuebased care at the end of life, and finally to include decisions about physician-assisted dying where relevant to the policy context.
First, going on 10 years since we embarked on a systematic review of the evidence on this topic, 3 it is still the case that relatively few researchers have observed directly how decision-making processes occur in palliative care practice and how the use of different types of decision support can improve this process. Researchers should always consider how decision-making processes are constructed through language and the unavoidable framing that occurs when decisions are deliberated in practice. A recent study of 41 audio-recorded consultations is a prime example; it revealed that joint deliberation and preference construction are not standard practice in decision-making about palliative chemotherapy. 4 The nature of palliative care decisions makes it particularly important to pay attention to deliberation and clinical conversations. These decisions encompass a sensitive emotional component, which is clear to anyone who has observed patients' and family members' reaction when receiving news about a terminal diagnosis. Moreover, there is significant uncertainty regarding patient outcomes. This uncertainty not only stems from the complexity of health problems encountered among terminally-ill patient populations, that is, multi-morbidity is high among older adults and it is not uncommon for patients to deal with more than one life-threatening diagnosis. It also stems from the quality of the evidence available for this patient population, making it difficult to provide precise information about the expected outcomes of therapeutic options. To complicate things further, the importance of maintaining hope can conflict with the assumption that patients need explicit and precise information to engage in shared decision-making. There is also a widespread assumption that healthcare providers' reluctance to have these conversations with patients and their families is partly responsible for overly aggressive care at the end of life. In sum, the practices of experienced palliative care providers who tackle these decisions and conversations daily should be studied further, as part of an effort to better understand current practices and potentially improve them with tailored interventions and decision aids.
Second, a major limitation of shared decision-making has been the difficulty to reconcile patient perceptions with provider or third-party assessments of complex decision-making interactions. The patient perspective is notoriously difficult to capture given the need to separate patient satisfaction with the decision-making process itself, from satisfaction with the outcomes of such decisions or other care processes. In this regard, the development of a simple three-question scale specifically designed to measure patient perceptions 5 is promising for use with palliative care patient populations, where frugal scales are paramount for feasibility. This scale moves away from difficult concepts like "decisions," "options," and "preferences," to ask patients how much effort has been made to help them understand their health issues, to listen to what matters most to them, and to include what matters most into choosing what to do next. 5 To date, there are no studies using this new patient-centered measure in the context of palliative care delivery.
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Editorial Palliative Medicine 31 (7) Third, palliative care practice and research has the unfortunate tendency to overlook patients with less predictable trajectories of terminal decline and that is equally the case for research about decision-making processes. The vast majority of studies rely on oncological patient populations. Yet large numbers of patients face non-cancer, lifethreatening diagnoses and the complex healthcare decisions that accompany organ failure and neurodegenerative diseases. A promising study on this topic is the PRagmatic trial Of Video Education in Nursing homes (PROVEN), which targets the completion of advance directives by all residents in two large nursing home chains as a way to reduce hospitalizations in line with patient preferences. 6 With 45% of US decedents having a nursing home stay in their last 90 days of life in 2009, 2 this study will document the effectiveness of a large-scale decision support intervention for noncancer, end-of-life care preferences and shed light on the challenges that arise when trying to change practices throughout the nursing home setting.
Fourth, there are larger forces at play in health systems as far as organizing end-of-life care is concerned, and as such the impact of various organizational features on patient involvement in palliative care decisions should be explored. The current shift in the US healthcare system from traditional fee-for-service volume-based incentives to what are called "value-based" care incentives as part of Accountable Care Organizations (ACOs) might drastically impact the implementation of shared decision-making. It is noteworthy that the latest national Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey for ACOs now includes questions to capture consumer satisfaction with decision-making processes. At this time, palliative care decisions are not targeted in the early implementation of shared decision-making in ACOs, but these types of reforms are an excellent opportunity to examine the association between shifts in payment structure as well as care coordination, and patient-level outcomes that include involvement in decision-making processes and the alignment between patient preferences and the end-of-life care provided. 7 Finally, a growing number of countries have been debating and/or legalizing physician-assisted dying, whether in the form of assisted suicide or euthanasia. Canada and Spain are the two latest examples, with the former adopting a national law in the past year and the latter in the midst of debate. While palliative care is traditionally defined as an approach that neither prolongs nor shortens life, non-involvement in these decisions appears difficult when policies include these interventions as part of end-of-life care options and do not set up a parallel system to evaluate requests. A large portion of patients receiving physician-assisted dying reported being enrolled in hospice and palliative care programmes. 8 These interventions represent a test of our healthcare systems and their ability to offer patients a real choice between physicianassisted dying and accessible palliative care options. The assessment of patients' and family members' involvement in decisions about physician-assisted dying and their understanding of palliative care options seems particularly important to guide the careful implementation of these ethically fraught policies. What little research has been conducted in contexts where these interventions are legal confirms the need for more effort to involve patients and their family members in decision-making processes. 9 In conclusion, promising research directions abound as far as the study of shared decision-making in the field of palliative care is concerned. The research priorities outlined follow a public health goal of ensuring widespread access to palliative care that is aligned with patients' values and preferences, and highlight the need for researchers to pay closer attention to the clinical and health system contexts where these end-of-life care preferences are deliberated.
